In line with the decrease in SUMOylated tau, DAPK1 inhibition also significantly suppressed tau phosphorylation at multiple AD-related sites, including AT8, pS262, pS396, and pT231 (Fig. 8D, E). Here, MAPT is linked to Alzheimer disease.